Beverley C. Almeida

Eaton Road
Liverpool, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Journal: Clinical rheumatology

Published: December 11, 2025

Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Correction: Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Journal: Clinical rheumatology

Published: December 11, 2025

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).

EULAR/ACR classification criteria for paediatric chronic nonbacterial osteomyelitis (CNO).

Journal: Annals of the rheumatic diseases

Published: September 11, 2024

EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis.

EULAR/American College of Rheumatology Classification Criteria for Pediatric Chronic Nonbacterial Osteomyelitis.

Journal: Arthritis & rheumatology (Hoboken, N.J.)

Published: September 11, 2024

Successful integration of an automated patient-reported outcome measure within a hospital electronic patient record.

Successful integration of an automated patient-reported outcome measure within a hospital electronic patient record.

Journal: Rheumatology advances in practice

Published: May 04, 2022

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Journal: Clinical rheumatology

Published: February 23, 2022

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Use of MRP8/14 in clinical practice as a predictor of outcome after methotrexate withdrawal in patients with juvenile idiopathic arthritis.

Journal: Clinical rheumatology

Published: February 23, 2022

γδ T cells compose a developmentally regulated intrauterine population and protect against vaginal candidiasis.

γδ T cells compose a developmentally regulated intrauterine population and protect against vaginal candidiasis.

Journal: Mucosal immunology

Published: October 31, 2019

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.

Multi-centre national audit of juvenile localised scleroderma: describing current UK practice in disease assessment and management.

Journal: Pediatric rheumatology online journal

Published: September 27, 2018

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.

Autoantibodies in juvenile-onset myositis: Their diagnostic value and associated clinical phenotype in a large UK cohort.

Journal: Journal of autoimmunity

Published: March 07, 2017

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.

Comparison of the Utility and Validity of Three Scoring Tools to Measure Skin Involvement in Patients With Juvenile Dermatomyositis.

Journal: Arthritis care & research

Published: September 29, 2015

Cardiovascular status after Kawasaki disease in the UK.

Cardiovascular status after Kawasaki disease in the UK.

Journal: Heart (British Cardiac Society)

Published: February 27, 2015

Showing 1-12 of 17

Last Updated: 09/26/2026